IPCALAB — Ipca Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹410.57bn
- IN₹421.10bn
- IN₹96.46bn
Brief: IPCA Laboratories Re-Appoints Ajit Kumar Jain As Joint MD For 5 Years
Brief: India's IPCA Laboratories June-Qtr Consol Net Profit Rises
Brief: Indian Pharma Firms Sent Notices By Govt Body For Introducing Drugs Without Approval
Brief: India's IPCA Laboratories March Quarter Profit From Cont Ops Rises
Brief: IPCA Labs Enter Share Purchase Agreement To Acquire Ramdev Chemical
India healthcare: Nomura expects a healthy Q4
Brief: India's Ipca Laboratories Dec-Qtr Profit From Cont Ops Rises
India's IPCA Laboratories: Nomura raises PT
Brief: India's IPCA Laboratories Sept-Qtr Profit Rises
Brief: IPCA Labs Says Unit Acquires 80 Pct Share Capital Of Bayshore Pharmaceuticals
India's Alkem to take maximum hit from combination drug ban - Nomura
Brief: India's IPCA Laboratories Posts June-Qtr Profit
Brief: India's IPCA Laboratories March-Qtr Profit From Cont Ops Rises
Brief: India's IPCA Labs Dec-Qtr Profit More Than Doubles
Brief: Ipca Laboratories' Units To Acquire Pisgah Labs For $9.65 Mln
Brief: India's IPCA Labs Sept-qtr profit up about 76 pct
Brief: Ipca Labs says The global Fund selected co as panel supplier of anti-malarial medicines
Brief: India's Ipca Laboratories posts June-qtr loss
Brief: Ipca Labs says U.S.FDA has not carried new inspections at co's Madhya Pradesh, Pithampur, Silvassa plants